Case Report
Severely Elevated Fecal Calprotectin in A Pediatric Patient with Persistent Giardiasis
Melissa Shapiro1, Neha Shah2 and Sona Sehgal1*
1Division of Gastroenterology and Hepatology, Nutrition Children’s National Hospital, USA
2Johns Hopkins Bloomberg School of Public Health, USA
Sona Sehgal, Division of Gastroenterology and Hepatology, Nutrition Children’s National Hospital, Washington, USA.
Received Date: December 15, 2020; Published Date: January 28, 2021
Introduction
Giardia, a protozoan pathogen, is a leading cause of acute gastroenteritis worldwide with higher prevalence in developing countries. It is a treatable diagnosis that should be considered in any patient presenting with clinical symptoms of abdominal pain, bloating, and diarrhea. It is diagnosed with stool microcopy, antigen testing, or immunologic assay. There are few studies on whether Giardia should be considered in the setting of elevated fecal calprotectin (FC), a stool biomarker of intestinal inflammation. We present the case of a patient with markedly elevated FC in the setting of persistent, severe giardiasis.
Keywords: Giardia lamblia; Giardiasis; Fecal calprotectin
Abbreviations: FC: Fecal Calprotectin
-
Melissa Shapiro, Neha Shah, Sona Sehgal. Severely Elevated Fecal Calprotectin in A Pediatric Patient with Persistent Giardiasis. Acad J Gastroenterol & Hepatol. 2(4): 2021. AJGH.MS.ID.000542.